ARCUTIS BIOTHERAPEUTICS
Arcutis Biotherapeutics is a privately held clinical-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology. The company was founded in 2016 and is based in Westlake Village, California.
ARCUTIS BIOTHERAPEUTICS
Industry:
Biopharma Biotechnology Health Diagnostics Pharmaceutical Therapeutics
Founded:
2016-01-06
Address:
Westlake Village, California, United States
Country:
United States
Website Url:
http://www.arcutis.com
Total Employee:
101+
Status:
Active
Contact:
805-418-5006
Email Addresses:
[email protected]
Total Funding:
583.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-09-08 | Ducentis BioTherapeutics | Ducentis BioTherapeutics acquired by Arcutis Biotherapeutics | 400 M USD |
Investors List
SLR Capital Partners
SLR Capital Partners investment in Post-IPO Debt - Arcutis Biotherapeutics
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series C - Arcutis Biotherapeutics
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Series C - Arcutis Biotherapeutics
RA Capital Management
RA Capital Management investment in Series C - Arcutis Biotherapeutics
BlackRock
BlackRock investment in Series C - Arcutis Biotherapeutics
Pivotal bioVenture Partners
Pivotal bioVenture Partners investment in Series C - Arcutis Biotherapeutics
Goldman Sachs
Goldman Sachs investment in Series C - Arcutis Biotherapeutics
Omega Funds
Omega Funds investment in Series C - Arcutis Biotherapeutics
OrbiMed
OrbiMed investment in Series C - Arcutis Biotherapeutics
Bain Capital
Bain Capital investment in Series C - Arcutis Biotherapeutics
Official Site Inspections
http://www.arcutis.com Semrush global rank: 4.02 M Semrush visits lastest month: 3.07 K
- Host name: 23.185.0.3
- IP address: 23.185.0.3
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Arcutis Biotherapeutics" on Search Engine
Medical dermatology innovation | Arcutis Biotherapeutics
Founded in 2016 by a global leadership team with extensive dermatology and commercialization experience—including 50+ FDA-approved products —Arcutis has 8 …See details»
About Us - Arcutis Biotherapeutics
Our executive and management team includes industry leaders with 50+ FDA-approved products between them, 7 dermatology clinicians, and medical dermatology’s foremost topical drug formulator. Our roots run …See details»
About Us | Arcutis Biotherapeutics
Meaningful innovation. at a glance. Download our corporate fact sheet intended for investors and shareholders. Get more information about Arcutis’ late-stage …See details»
Arcutis Biotherapeutics - Crunchbase Company Profile & Funding
Arcutis Biotherapeutics is a privately held clinical-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune …See details»
Arcutis Announces Acquisition of Ducentis BioTherapeutics Ltd.
WESTLAKE VILLAGE, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), an early commercial-stage biopharmaceutical …See details»
Our Approach to Clinical Trials - About Us | Arcutis Biotherapeutics
Our Approach to Clinical Trials - About Us | Arcutis Biotherapeutics. Committed to. Diverse and Inclusive. Clinical Trials. Arcutis believes that an essential part of …See details»
Meaningful Innovation - Arcutis Biotherapeutics
Better treatments. Better quality of life. That’s why we’re here. A unique medical dermatology development platform. At Arcutis, meaningful innovation means focusing …See details»
Arcutis Announces Additions to its Investor Relations and ...
Aug 2, 2021 Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) is a medical dermatology company that champions meaningful innovation to address the urgent needs of patients …See details»
Our Approach to Clinical Trials - Arcutis Biotherapeutics
Our Approach to Clinical Trials - Arcutis Biotherapeutics. About Arcutis. Committed to diverse and inclusive clinical trials. Arcutis believes that an essential part of developing …See details»
Arcutis Announces Acquisition of Ducentis BioTherapeutics Ltd.
Sep 7, 2022 WESTLAKE VILLAGE, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), an early commercial-stage …See details»
Arcutis Announces Leadership Transition - Arcutis Biotherapeutics
May 24, 2023 WESTLAKE VILLAGE, Calif., May 24, 2023 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), an early commercial-stage …See details»
Corporate Governance - Arcutis Biotherapeutics
Corporate Governance - Arcutis Biotherapeutics. The Board of Directors of Arcutis Biotherapeutics (the "Company") sets high standards for the Company's employees, …See details»
Arcutis Stock: Sales Expansion Momentum Puts It On A Good …
May 20, 2024 The use of Arcutis Biotherapeutics' Zoryve for plaque psoriasis patients was expanded to include patients between the ages of 6 and 11. Sales of Zoryve grew …See details»
Investors - Arcutis Biotherapeutics
Corporate Profile. Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) is an early commercial-stage medical dermatology company that champions meaningful innovation to address …See details»
Arcutis Biotherapeutics Inc (ARQT) Q1 2024 Earnings Call …
Release Date: May 14, 2024. For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points. Arcutis Biotherapeutics Inc ( …See details»
Arcutis Canada Submission for Roflumilast Cream 0.15
4 days ago Arcutis Canada, Inc. is a subsidiary of Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a medical dermatology company that champions meaningful …See details»
Arcutis Biotherapeutics - Funding, Financials, Valuation & Investors
Highlights. Stock Symbol NASDAQ:ARQT. Funding Rounds 8. Total Funding Amount. Unlock for free. Lead Investors 4. Investors 12. Funding. Arcutis Biotherapeutics has …See details»
Analysts Are Betting On Arcutis Biotherapeutics, Inc.
May 24, 2024 View our latest analysis for Arcutis Biotherapeutics. Additionally, the consensus price target for Arcutis Biotherapeutics increased 5.6% to US$19.00, …See details»
Our Products | Arcutis Biotherapeutics
Product list. Product Monograph. Patient Medication Information. Meaningful innovation. at a glance. Download our corporate fact sheet intended for investors and shareholders. …See details»
Annual Reports - Arcutis Biotherapeutics
The Investor Relations website contains information about Arcutis Biotherapeutics's business for stockholders, potential investors, and financial analysts.See details»